16:04 EST Sarepta (SRPT) files automatic mixed securities shelf
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT:
- Sarepta Therapeutics’ Earnings Call Highlights Record Growth
- Sarepta Therapeutics Inc. Earnings Report: Did it Beat Expectations?
- Sarepta price target lowered to $210 from $217 at BofA
- Sarepta price target raised to $196 from $195 at Morgan Stanley
- Optimistic Buy Rating for Sarepta Therapeutics Driven by Elevidys Potential and Expanding Pipeline